viewMediclinic International Plc

Mediclinic in red after write-downs at Spire and in Switzerland

Mediclinic’s bid for the outstanding 70% of Spire was rejected by the UK healthcare group

Lots of red at Mediclinic

Hospital group Mediclinic International Plc (LON:MDC) plunged into the red on write-offs on investments in Switzerland and Spire Healthcare PLC (LON:SPI).

Mediclinic’s bid for the outstanding 70% of Spire was rejected by the UK healthcare group in November leading to the subsequent collapse of talks.

READ: Mediclinic nudges up guidance after strong second half for its Middle East division

Spire’s value had slumped after it paid out £37mln compensation to women treated by disgraced surgeon Ian Paterson.

South Africa-based Mediclinic, which runs hospitals in Africa, Switzerland and the Middle East,  posted a loss of £492mln in the year to March after a £109mln charge for Spire and £644mln at Swiss group Hirslanden.

Mediclinic also incurred £23mln of costs rebranding its Al-Noor acquisition.

Revenues over the year were 4% higher at £2.87bn with underlying profits 3% better at £515mln.

Shares fell 4% to 650p.

Quick facts: Mediclinic International Plc

Price: 395.7 GBX

Market: LSE
Market Cap: £2.92 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



NQ Minerals' David Lenigas focused on restructuring debt and upping profits...

NQ Minerals PLC's (LON:NQMI) David Lenigas speaks to Proactive London's Andrew Scott soon after taking over as chairman at the Australia-focused mining group. Production and exploration plans aside, Lenigas also says they're in advanced talks to replace on more favourable terms all the debt...

19 minutes ago

2 min read